جريدة الرياض | أدبي الطائف يعلن الفائزين بجائزة الشاعر محمد الثبيتي للإبداع
alriyadh.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alriyadh.com Daily Mail and Mail on Sunday newspapers.
لنجاحها في تحقيق مستهدفات المالية بلدي الشرقية يثمّن جهود ا
sabq.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sabq.org Daily Mail and Mail on Sunday newspapers.
The Georgia Coalition for Higher Education in Prison (GACHEP) announced that
Stacy Bell, professor of pedagogy in English at Oxford College, will serve as co-president of the nonprofit organization s first board of directors.
GACHEP is a coalition of higher education institutions providing college-level programs in Georgia prisons. The organization serves to build high-quality educational pathways, from pre-college coursework to accredited degree completion, for people who are in prison and people who have left prison in Georgia.
Pulitzer Prize-winning poet
Jericho Brown will be celebrated as one of the newest members of the Georgia Writers Hall of Fame in November. The four 2021 inductees join a group of 69 acclaimed wordsmiths, including recipients of prestigious creative awards such as the Pulitzer Prize, the Academy Awards and even the Nobel Peace Prize.
Eyenovia Announces Appointment of Renowned Ophthalmologist and Scientific Leader Dr. Julia Haller to its Board of Directors
By
Staff
58 seconds ago
NEW YORK–(BUSINESS WIRE)–#EYEN Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array print (MAP™) platform technology, today announced the appointment of renowned ophthalmologist and scientific leader, Julia Haller, M.D., to its Board of Directors.
“We are delighted to welcome Dr. Haller to our Board of Directors at such an exciting time for Eyenovia,” commented Dr. Sean Ianchulev, Chief Executive Officer and Chief Medical Officer of Eyenovia. “We believe that Dr. Haller’s decades of experience as an esteemed ophthalmic surgeon, scientist, professor, and business leader will be invaluable to the Eyenovia team as we strive to advance our late-stage ophthalmic pipeline and work towards our near-term clinical and regulato